Innovotherapeutics inc.Daejeon, South Korea
Pharmacology Team Member at a Drug Development Company
0875: INV-1498, a Promising Caspase Inhibitor, Exhibits Dose-dependent Therapeutic Efficacy in a Canine Model of Osteoarthritis
Monday, November 13, 20239:00 AM – 11:00 AM PT
Disclosure information not submitted.